You have 9 free searches left this month | for more free features.

WM

Showing 26 - 50 of 3,092

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stress Urinary Incontinence, Cell Therapy Trial in Royal Oak, Nashville, Toronto (autologous muscle cell injection)

Completed
  • Stress Urinary Incontinence
  • Cell Therapy
  • autologous muscle cell injection
  • Royal Oak, Michigan
  • +2 more
Jun 29, 2021

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Duarte, California
  • +10 more
Jul 14, 2022

Waldenström Macroglobulinemia (WM) Trial in Worldwide (Acalabrutinib (ACP-196))

Active, not recruiting
  • Waldenström Macroglobulinemia (WM)
  • Acalabrutinib (ACP-196)
  • Santa Barbara, California
  • +37 more
Mar 17, 2022

Waldenstrom's Macroglobulinemia Trial in Boston (Bortezomib, Rituximab)

Completed
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Oct 6, 2020

Diabetes Trial in Odense (WM3.4)

Terminated
  • Diabetes
  • WM3.4
  • Odense, Denmark
    Department of Endocrinology M, Odense University Hospital
Oct 6, 2020

Waldenström's Macroglobulinemia Trial in Worldwide (BGB-3111, Ibrutinib)

Completed
  • Waldenström's Macroglobulinemia
  • Phoenix, Arizona
  • +79 more
Jul 6, 2022

Opioid Medication Assisted Treatment Trial in United States (Implementation Facilitation)

Enrolling by invitation
  • Opioid Medication Assisted Treatment
  • Implementation Facilitation
  • Birmingham, Alabama
  • +10 more
Nov 16, 2021

Mid Face Volume Deficit Trial in Canada, Spain, United Kingdom (HArmonyCa Lidocaine Injectable Gel)

Recruiting
  • Mid Face Volume Deficit
  • HArmonyCa Lidocaine Injectable Gel
  • Vancouver, British Columbia, Canada
  • +14 more
Jul 19, 2022

Heart Failure Trial in Columbia (Exercise)

Completed
  • Heart Failure
  • Exercise
  • Columbia, South Carolina
    Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC
May 18, 2020

Working Memory Trial in East Providence (Active Intermittent Theta Burst Stimulation, Sham Intermittent Theta Burst Stimulation)

Recruiting
  • Working Memory
  • Active Intermittent Theta Burst Stimulation
  • Sham Intermittent Theta Burst Stimulation
  • East Providence, Rhode Island
    E. P. Bradley Hospital
Jan 4, 2023

Executive Dysfunction Trial in Tallahassee (Steep-tRAS, Flat-tRAS, Sham-tRAS)

Not yet recruiting
  • Executive Dysfunction
  • Steep-tRAS
  • +2 more
  • Tallahassee, Florida
    Florida State University
Nov 9, 2023

Post-traumatic Stress Disorder Trial in Madison (prednisone, )

Completed
  • Post-traumatic Stress Disorder
  • Madison, Wisconsin
  • +1 more
Apr 27, 2020

Waldenstrom's Macroglobulinaemia Trial in United Kingdom (Bortezomib, Cyclophosphamide, Rituximab)

Completed
  • Waldenstrom's Macroglobulinaemia
  • Basingstoke, United Kingdom
  • +29 more
Jun 17, 2021

Cognitive Rehabilitation, Brain Injuries, Cognitive Impairment Trial in Nesoddtangen (Hypnotic suggestion, Mindfulness)

Recruiting
  • Cognitive Rehabilitation
  • +3 more
  • Hypnotic suggestion
  • Mindfulness
  • Nesoddtangen, Viken, Norway
    Sunnaas Rehabilitation Hospital
Nov 7, 2022

Waldenstrom Macroglobulinemia Trial (Venetoclax; Rituximab, DRC)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • Venetoclax; Rituximab
  • DRC
  • (no location specified)
Nov 4, 2022

Waldenstrom's Macroglobulinemia Trial in Houston (Bortezomib, Rituximab, Valacyclovir)

Active, not recruiting
  • Waldenstrom's Macroglobulinemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 5, 2022

Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory Trial

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • +2 more
  • (no location specified)
Jul 18, 2023

Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)

Completed
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
  • +1 more
Dec 5, 2022

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

Waldenstrom's Disease, Prognostic Index Trial in France

Not yet recruiting
  • Waldenstrom's Disease
  • Prognostic Index
    • Amiens, France
    • +14 more
    Jun 12, 2023

    Memory Deficits, Schizophrenia, Neurostimulator; Complications Trial in Taipei (STARSTIM)

    Completed
    • Memory Deficits
    • +2 more
    • STARSTIM
    • Taipei, Taiwan
      Shuang-Ho Hospital
    Aug 9, 2022

    Mild Cognitive Impairment Trial in Valparaíso (Combined tACS and Cognitive Training Program, Traditional Cognitive Training

    Recruiting
    • Mild Cognitive Impairment
    • Combined tACS and Cognitive Training Program
    • Traditional Cognitive Training Program
    • Valparaíso, Quinta Región, Chile
      Centro de Investigación del Desarrollo de Cognición y Lenguaje,
    Oct 17, 2022

    Lesion Load and Location in Relation to Cognition, Fatigue and

    Completed
    • Relapsing Remitting Multiple Sclerosis
    • VolBrain, a fully automated platform to generate the volumetric data (lesion count, volume and location as well as different atrophy measures)
    • Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
    • Assiut, Egypt
      Eman Khedr
    Oct 27, 2022

    Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • B-Cell Lymphoproliferative Disorder
    • Boston, Massachusetts
    • +2 more
    Feb 18, 2023

    HIV Infection Trial in Baltimore (Adaptive WM CogMed Training, Nonadaptive WM CogMed Training)

    Unknown status
    • HIV Infection
    • Adaptive WM CogMed Training
    • Nonadaptive WM CogMed Training
    • Baltimore, Maryland
      University of Maryland School of Medicine
    Oct 1, 2019